Related Experiment Video
Updated: Sep 3, 2025
05:04
Author Spotlight: Evaluating Clinicians' Adoption of Ultrasound-Guided Vascular Cannulation Through Simulation Training
Published on: August 9, 2024
1.1K
Exploring Illinois contraceptive providers' interest in medication abortion training
Lee Hasselbacher1, Amy Moore1, Lee Thompson1
1University of Chicago, Chicago, IL, United States.
Contraception
|July 23, 2022
Summary
More than half of Illinois contraceptive providers surveyed expressed interest in medication abortion training. This highlights a need for further research into training accessibility for medication abortion services.
Area of Science:
- Reproductive Health
- Medical Education
- Public Health Policy
Background:
- Medication abortion is a critical component of reproductive healthcare.
- Understanding provider interest in training is essential for expanding access to medication abortion services.
Purpose of the Study:
- To assess the interest level of Illinois contraceptive providers in receiving training on medication abortion.
- To identify provider, practice, and patient factors associated with interest in medication abortion training.
Main Methods:
- A survey was distributed to Illinois contraceptive providers.
- Data analysis explored associations between interest in medication abortion training and various provider and practice characteristics.
Main Results:
- A 24% response rate was achieved from 1040 eligible contacts, with 251 providers responding.
- Over half (56%) of respondents expressed interest in medication abortion training.
- Highest interest was observed among providers with less than two days of formal contraceptive training (76%) and those receiving Title X funding (81%).
Conclusions:
- A significant proportion of Illinois contraceptive providers are interested in medication abortion training.
- Further investigation is warranted to determine if enhanced training can increase the number of providers offering medication abortion counseling, referrals, and services.
Related Concept Videos
01:22Birth Control Methods
2.2K
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
2.2K
01:26Drug Administration and Therapy Phases: Overview
691
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
691
01:17Drugs for Treatment of Diarrhea-Predominant IBS
282
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
282
01:11Clinical Trials: Overview
3.3K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.3K
01:29Drug Delivery: Parenteral Route
793
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
793